Drugs / Human Diploid Cell Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01228383 | Dec 2011 → Oct 2012 | rabies | Crucell Holland BV | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01148459 Comparator | Jul 2010 → May 2013 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human diploid cell vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01228383 ↗ |
| Known as | HDCV | “Human Diploid Cell Vaccine (HDCV) or Purified Vero Cell Rabies Vaccine (PVRV, Verorab) (Aventis Pasteur);” NCT01148459 ↗1“Human diploid cell vaccine (HDCV)” NCT01228383 ↗ |
| Modality | Vaccine | “Human Diploid Cell Vaccine” NCT01148459 ↗ |